2021•Journal of Innovations in Applied Pharmaceutical Science (JIAPS)Requires access

Formulation development and stability studies of bilayer tablets of linagliptin and metformin

Saibabu Ch, R Raviteja

Open publisher page 1 citations

Abstract

In vitro release studies were carried out by USP type 2 paddle apparatus. The results showed that Eudragit’s in a sustained layer can control the release of drugs. The in vitro release profile of the drug from the sustained-release layer could be expressed by Higuchi's equation as the pilot shows high linearity R2 =0.9911and diffusion was the dominant mechanism of drug release. The formulation (F6) having an immediate-release layer produces an immediate effect of 93.53 ± 0.30 within 45 minutes followed by a sustained release effect of 94.77 ± 0.37 up to 8 hours. The present study concluded that Bilayer tablets of Lingaptin and Metformin HCl can be a better alternative to conventional dosage forms for providing sustained drug delivery.

About this research paper

What this paper is about

In vitro release studies were carried out by USP type 2 paddle apparatus. The results showed that Eudragit’s in a sustained layer can control the release of drugs. The in vitro release profile of the drug from the sustained-release layer could be expressed by Higuchi's equation as the pilot shows high linearity R2 =0.9911and diffusion was the dominant mechanism of drug release. The formulation (F6) having an immediate-release layer produces an immediate effect of 93.53 ± 0.30 within 45 minutes followed by a sustained release effect of 94.77 ± 0.37 up to 8 hours. The present study concluded that Bilayer tablets of Lingaptin and Metformin HCl can be a better alternative to conventional dosage forms for providing sustained drug delivery.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In vitro release studies were carried out by USP type 2 paddle apparatus. The results showed that Eudragit’s in a sustained layer can control the release of drugs. The in vitro release profile of the drug from the sustained-release layer could be expressed by Higuchi's equation as the pilot shows high linearity R2 =0.9911and diffusion was the dominant mechanism of drug release. The formulation (F6) having an immediate-release layer produces an immediate effect of 93.53 ± 0.30 within 45 minutes followed by a sustained release effect of 94.77 ± 0.37 up to 8 hours. The present study concluded that Bilayer tablets of Lingaptin and Metformin HCl can be a better alternative to conventional dosage forms for providing sustained drug delivery.

Key concepts: Metformin, Bilayer, Pharmacology, Chemistry, Drug, Diffusion, Linagliptin, Immediate release

Related papers

Back to paper searchBrowse research topicsOriginal source
Formulation development and stability studies of bilayer tablets of linagliptin and metformin — Research Paper | ScholarLens